Seeking Alpha
 

Cumberland Pharmaceuticals Inc. (CPIX)

- NASDAQ
  • Tue, Mar. 3, 4:32 PM
    • Cumberland Pharmaceuticals (NASDAQ:CPIX): Q4 EPS of $0.10
    • Revenue of $9.3M (+13.4% Y/Y)
    • Press Release
    | Comment!
  • Nov. 5, 2014, 12:47 AM
    • Cumberland Pharmaceuticals (NASDAQ:CPIX): Q3 EPS of $0.04
    • Revenue of $9.7M (+49.2% Y/Y)
    • Press Release
    | Comment!
  • Aug. 5, 2014, 4:50 PM
    • Cumberland Pharmaceuticals (NASDAQ:CPIX): Q2 EPS of $0.04
    • Revenue of $9.75M (+37.7% Y/Y)
    • Press Release
    | Comment!
  • May. 13, 2014, 5:24 PM
    • Cumberland Pharmaceuticals (CPIX): FQ1 EPS of $0.02
    • Revenue of $8.1M (-21% Y/Y)
    • Press Release
    | Comment!
  • Mar. 4, 2014, 4:49 PM
    • Cumberland Pharmaceuticals Inc. (CPIX): Q4 EPS of -$0.08 misses by $0.13.
    • Revenue of $8.15M (-40.5% Y/Y) misses by $0.04M.
    • Press Release
    | Comment!
  • Nov. 5, 2013, 5:39 PM
    • Cumberland Pharma (CPIX): Q3 EPS of -$0.04.
    • Revenue of $6.5M misses by $1.1M. (PR)
    | Comment!
  • Aug. 7, 2013, 11:46 AM
    • Cumberland Pharmaceutical (CPIX -14%) slides after reporting worse-than-expected Q2 results late yesterday.
    • The company swung to a net loss of $0.03 per share, compared with a profit of $0.9 a year ago. Analysts had expected a profit of $0.02.
    • Net revenue declined to $7.1M from $12.4M for the prior year period, below forecasts for $9.4M.
    • Sales were Down 43% year over year.
    | Comment!
  • Aug. 6, 2013, 4:56 PM
    • Cumberland Pharmaceuticals (CPIX): Q2 EPS of -$0.03 misses by $0.05.
    • Revenue of $7.08M misses by $2.32M. (PR)
    | Comment!
  • May. 2, 2013, 7:19 PM
    Cumberland Pharmaceuticals (CPIX): Q1 EPS of $0.05 in-line. Revenue of $10.3M beats by $0.3M. (PR)
    | Comment!
  • Feb. 28, 2013, 4:52 PM
    Cumberland Pharmaceuticals (CPIX): Q4 EPS of $0.09 misses by $0.05. Revenue of $13.7M misses by $0.17M. (PR)
    | Comment!
  • Jan. 29, 2013, 2:53 PM
    Cumberland Pharmaceuticals (CPIX +3.4%) gains today after it enters into an exclusive agreement with Indonesia's SOHO Industri Pharmasi for the Indonesian marketing of its of Caldolor Injection, which is used to treat pain and fever in hospitals. The deal gives SOHO an exclusive license, leaving it responsible for regulatory approval, reporting, product marketing, distribution and sales once approved. In exchange, CPIX will receive upfront and milestone payments, as well as transfer prices on future drug sales.
    | Comment!
  • Nov. 30, 2012, 5:42 PM
    Cumberland Pharmaceuticals (CPIX) announces a realignment of its national sales organization in the U.S. As a result, the company’s sales staff has been reduced from 95 to 64 individuals and its number of nationwide districts has been consolidated from 10 to 8. The company expects to incur between $500,00 and $750,000 in one-time related separation expenses during Q4. The impact on earnings will be addressed in its 2013 guidance.
    | Comment!
  • Nov. 9, 2012, 9:10 AM
    Premarket gainers: ZIP +27%. KYAK +26%. LGF +9%. ENR +8%. PSTI +8%. IGT +7%. WCRX +6%. ISIS +5%.
    Losers: GRPN -23%. MTG -15%. ARRY -12%. PGRX -12%. SPRD -10%. JCP -8%. PVR -6%. CPIX -5%. DIS -5%.
    | 1 Comment
  • Nov. 1, 2012, 6:51 PM
    Cumberland Pharmaceuticals (CPIX): Q3 EPS of $0.10 beats by $0.01. Revenue of $12.5M (-4.5% Y/Y) misses by $0.5M. (PR)
    | Comment!
  • Aug. 2, 2012, 5:26 PM
    Cumberland Pharmaceuticals (CPIX): Q2 EPS of $0.09 beats by $0.02. Revenue of $12.4M (-12.5% Y/Y) misses by $0.3M. (PR)
    | Comment!
  • May. 3, 2012, 5:58 PM
    Cumberland Pharma (CPIX): Q1 EPS of $0.02 misses by $0.03. Revenue of $10.3M (-3.9% Y/Y) misses by $2.5M. (PR)
    | Comment!
Visit Seeking Alpha's
CPIX vs. ETF Alternatives
Company Description
Cumberland Pharmaceuticals Inc is a specialty pharmaceutical company. It is engaged in the acquisition, development and commercialization of branded prescription products. Itstarget markets are hospital acute care and gastroenterology.